Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

Author： Bidstrup Tanja   Stilling Nicolaj   Damkier Per   Scharling Birgitte   Thomsen Mikael   Brøsen Kim  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.60, Iss.2, 2004-04, pp. : 109-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Metabolism of Zolmitriptan: Effects of an Inducer and an Inhibitor of Cytochrome P450 on its Pharmacokinetics in Healthy Volunteers

By Dixon R.   French S.   Kemp J.   Sellers M.   Yates R.  

Clinical Drug Investigation, Vol. 15, Iss. 6, 1998-06 ,pp. : 515-522

Adis International

Access to resources Recommend Favorite

Repaglinide

By Balfour J.A.   Faulds D.  

Drugs & Aging, Vol. 13, Iss. 2, 1998-08 ,pp. : 173-180

Adis International

Access to resources Recommend Favorite

Modulation of rifampicin toxicity by 6 MFA, an interferon inducer obtained from fungus Aspergillus ochraceus

By Dhuley J.N.   Naik S.R.  

Environmental Toxicology and Pharmacology, Vol. 5, Iss. 4, 1998-06 ,pp. : 237-243

Elsevier

Access to resources Recommend Favorite

Metabolism of the Novel IMP Dehydrogenase Inhibitor Benzamide Riboside

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 2, 2004-01 ,pp. : 225-229

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolism of the Novel IMP Dehydrogenase Inhibitor Benzamide Riboside

By  

Current Medicinal Chemistry, Vol. 9, Iss. 7, 2002-04 ,pp. : 781-786

Bentham Science Publishers

Access to resources Recommend Favorite